Related Experiment Video

Updated: Mar 29, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.7K

STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential

Stefan Chmielewski1,2, Anna Piaszyk-Borychowska1, Joanna Wesoly3

  • 1a Department of Human Molecular Genetics , Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University , Poznan , Poland.

International Reviews of Immunology
|November 26, 2015
PubMed

Insights

Signal Transducer and Activator of Transcription (STAT)1 and Interferon Regulatory Factor (IRF)8 play key roles in cardiovascular disease (CVD) inflammation. These factors orchestrate inflammatory responses in vascular cells, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Medicine

Background:

  • Inflammation is central to cardiovascular disease (CVD) pathophysiology.
  • Signal Transducer and Activator of Transcription (STAT)1 is crucial in immune responses and its role in CVD is recognized.
  • STAT1 mediates cross-talk between Interferon gamma (IFNγ) and Toll-like Receptor 4 activators (TLR4-A), amplifying inflammation.

Purpose of the Study:

  • To review the novel roles of STAT1 and Interferon Regulatory Factor (IRF)8 in vascular inflammation.
  • To highlight the transcriptional platform orchestrated by STAT1 and IRF8 in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs).
  • To identify potential biomarkers and therapeutic targets for CVD.

Main Methods:

  • Literature review summarizing recent findings on STAT1 and IRF8 in vascular cells.
  • Analysis of the interplay between IFNγ, TLR4-A, STAT1, and IRF8 in pro-atherogenic responses.
  • Identification of STAT1- and IRF8-target genes.

Main Results:

  • STAT1 and IRF8 orchestrate a transcriptional platform in ECs and VSMCs for IFNγ and TLR4-A cross-talk.
  • This interaction amplifies pro-atherogenic responses, indicating an inflammation-dependent role for IRF8 in vascular cells.
  • STAT1 and IRF8 target genes are implicated in vascular inflammation.

Conclusions:

  • STAT1 and IRF8 are critical regulators of vascular inflammation in CVD.
  • STAT1- and IRF8-target genes may serve as promising biomarkers for vascular inflammation.
  • STAT1 and IRF8 represent potential therapeutic targets for novel immunosuppressive and anti-inflammatory agents in CVD treatment.

Keywords:
IFNγIRF8STAT1TLR4atherosclerosisdiagnostic markersignal integrationtherapeutic target

More Related Videos

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

20.6K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
18.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K